Evaluation of diagnostic accuracy and side effects of endometrial biopsy curette

Evaluation of diagnostic accuracy and side effects of endometrial biopsy curette, a product of Slamtyar Hakim Engineering Company

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151120025139N2

Enrollment

Registered

2022-01-23

Start date

2021-11-22

Completion date

Unknown

Last updated

2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine endometrial biopsy. Malignant neoplasm of uterus, part unspecified

Interventions

Intervention 1: Control group:Including 60 patients, dilatation and curettage operation will be performed for endometrial biopsy. Intervention 2: Intervention group:Including 60 patients, endometrial

Eligibility

Sex/Gender

Female

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Age range 75-18 Willingness to participate in the study

Exclusion criteria

Exclusion criteria: History of endometrial cancer History of atypical endometrial hyperplasia Positive pregnancy test result Reluctance to participate

Design outcomes

Primary

Measure	Time frame
Pathological outcome. Timepoint: 10 days after biopsy. Method of measurement: Pathological evaluation.;Patients' pain intensity. Timepoint: Immediately after sampling. Method of measurement: Observation and questioning of the patient.;Complications after biopsy. Timepoint: After sampling. Method of measurement: Observe symptoms in the patient.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Maghool

Poursina Hakim Research center

fmaghool@gmail.com+98 31 3554 8151

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026